glp 1 cirrhosis Why are GLP-1 agonists being used to treat patients with nonalcoholic fatty liver disease? GLP-1 Agonists May Lower Cirrhosis,
Description
GLP-1 = glucagon-like peptide-1
10.1530/ec-23-0284 19
Programs in this model typically include virtual clinical evaluation, provider-issued prescriptions, and either brand-name FDA-approved GLP-1 dispensing or compounded semaglutide/tirzepatide via licensed compounding pharmacy pathways
[DOI] [PubMed] [Google Scholar] 186.Vanbuskirk K.A., Potenza M.N
